İ. Gökmen, E. Taştekin, A. Gökyer, Sezin Sayın, I. Çiçin
{"title":"Distribution Data of Epidermal Growth Factor Receptor Mutations Detected by Next-Generation Sequencing Method in Non-Small Cell Lung Cancer","authors":"İ. Gökmen, E. Taştekin, A. Gökyer, Sezin Sayın, I. Çiçin","doi":"10.37047/jos.2021-84407","DOIUrl":null,"url":null,"abstract":"diagnosis and treatment, the incidence of lung cancer remains high both in Turkey and worldwide, and it is one of the leading causes of cancer-related deaths.1 When we evaluate Turkey, according to the age-standardized cancer rate in males, lung cancer occupies first place with 57.7%, and in females, it is at fifth place with 9.8%. 80% of lung cancer cases are nonsmall cell lung cancer (NSCLC), most of them are diagnosed at an advanced stage, and only 19% of patients can live for five years or longer.2 The dominant histological subtype in NSCLC is adenocarcinoma both in the world and in Turkey (47.1%).3","PeriodicalId":31838,"journal":{"name":"Journal of Oncological Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Oncological Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37047/jos.2021-84407","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
diagnosis and treatment, the incidence of lung cancer remains high both in Turkey and worldwide, and it is one of the leading causes of cancer-related deaths.1 When we evaluate Turkey, according to the age-standardized cancer rate in males, lung cancer occupies first place with 57.7%, and in females, it is at fifth place with 9.8%. 80% of lung cancer cases are nonsmall cell lung cancer (NSCLC), most of them are diagnosed at an advanced stage, and only 19% of patients can live for five years or longer.2 The dominant histological subtype in NSCLC is adenocarcinoma both in the world and in Turkey (47.1%).3
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
